Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model.

Kim, Jaeryung; Kim, Tae Eun; Kim, Ju-A; Yun, Ji-Hyun; Sohn, Seongsoo; Shim, Sang Ryeol; Lee, Sang Hoon; Kim, Sang Jin

Kim, Jaeryung; Kim, Tae Eun; Kim, Ju-A; Yun, Ji-Hyun; Sohn, Seongsoo; Shim, Sang Ryeol; Lee, Sang Hoon; Kim, Sang Jin.

Affiliation

Kim J; 1 The Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST) , Daejeon, Republic of Korea.

J Ocul Pharmacol Ther ; 30(10): 847-53, 2014 Dec.

Article de En | MEDLINE | ID: mdl-25188901

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néovascularisation choroïdienne / Anticorps monoclonaux Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies Limites: Animals / Humans Langue: En Journal: J Ocul Pharmacol Ther Sujet du journal: FARMACOLOGIA / OFTALMOLOGIA / TERAPEUTICA Année: 2014 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google